These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2935528

  • 1. Activation of plasminogen by pro-urokinase. I. Mechanism.
    Lijnen HR, Zamarron C, Blaber M, Winkler ME, Collen D.
    J Biol Chem; 1986 Jan 25; 261(3):1253-8. PubMed ID: 2935528
    [Abstract] [Full Text] [Related]

  • 2. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
    Liu JN, Gurewich V.
    Blood; 1993 Feb 15; 81(4):980-7. PubMed ID: 8428004
    [Abstract] [Full Text] [Related]

  • 3. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN, Gurewich V.
    Biochemistry; 1992 Jul 14; 31(27):6311-7. PubMed ID: 1385727
    [Abstract] [Full Text] [Related]

  • 4. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
    Liu JN, Pannell R, Gurewich V.
    J Biol Chem; 1992 Aug 05; 267(22):15289-92. PubMed ID: 1639775
    [Abstract] [Full Text] [Related]

  • 5. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R, Fears R, Smith RA.
    Biochem J; 1987 Oct 15; 247(2):395-400. PubMed ID: 3122725
    [Abstract] [Full Text] [Related]

  • 6. Activation of plasminogen by pro-urokinase. II. Kinetics.
    Collen D, Zamarron C, Lijnen HR, Hoylaerts M.
    J Biol Chem; 1986 Jan 25; 261(3):1259-66. PubMed ID: 2935529
    [Abstract] [Full Text] [Related]

  • 7. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
    Harpel PC, Chang TS, Verderber E.
    J Biol Chem; 1985 Apr 10; 260(7):4432-40. PubMed ID: 3156857
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Aug 05; 262(22):10855-62. PubMed ID: 2956260
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments.
    Gurewich V, Pannell R.
    Blood; 1987 Mar 05; 69(3):769-72. PubMed ID: 2949785
    [Abstract] [Full Text] [Related]

  • 10. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.
    Pannell R, Gurewich V.
    Blood; 1986 May 05; 67(5):1215-23. PubMed ID: 3083889
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC.
    Eur J Biochem; 1997 Apr 15; 245(2):316-23. PubMed ID: 9151959
    [Abstract] [Full Text] [Related]

  • 12. Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture.
    Rijken DC, Binnema DJ, Los P.
    Thromb Res; 1986 Jun 15; 42(6):761-8. PubMed ID: 2425448
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN, Gurewich V.
    J Clin Invest; 1991 Dec 15; 88(6):2012-7. PubMed ID: 1836471
    [Abstract] [Full Text] [Related]

  • 14. A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma.
    Declerck PJ, Lijnen HR, Verstreken M, Moreau H, Collen D.
    Blood; 1990 May 01; 75(9):1794-800. PubMed ID: 1691934
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
    Lijnen HR, Van Hoef B, Nelles L, Collen D.
    J Biol Chem; 1990 Mar 25; 265(9):5232-6. PubMed ID: 1969415
    [Abstract] [Full Text] [Related]

  • 19. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S, Müllertz S, Suenson E, Kok P.
    Biochem J; 1984 Oct 01; 223(1):179-87. PubMed ID: 6208894
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein(a): a kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator.
    Liu JN, Harpel PC, Pannell R, Gurewich V.
    Biochemistry; 1993 Sep 21; 32(37):9694-700. PubMed ID: 8373773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.